Moreover, our meta-analysis determined that there was no association between TIMP-2 expression and the WHO grade of gliomas, and the overall trend of MMP-2 expression and glioma grade was not changed in studies which have reported both MMP-2 and TIMP-2 expressions. The gene discussed is TIMP2; the disease is central nervous system cancer.